Camber Pharma launches generic Trilepta
PISCATAWAY, N.J. – Camber Pharmaceuticals announces the addition of oxcarbazepine tablets to their current portfolio. Oxcarbazepine tablets are indicated in use as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults and as monotherapy in the treatment of partial-onset seizures in pediatric patients aged 4 years and above, and as adjunctive therapy in pediatric patients
